[THE CORONARY SINUS REDUCER: A DEVICEBASED THERAPY FOR REFRACTORY ANGINA]

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Biomedical Engineering

Background:

• Severe coronary artery disease (CAD) poses challenges for revascularization.
• Refractory angina persists in some CAD patients despite optimal medical therapy.
• Novel therapeutic strategies are needed for debilitating angina.

Purpose of the Study:

• To evaluate the Coronary Sinus (CS) Reducer as a treatment for refractory angina.
• To assess the impact of CS Reducer implantation on myocardial blood flow and angina symptoms.

Main Methods:

• The CS Reducer, a stainless steel device, is implanted percutaneously into the coronary sinus.
• The device creates a controlled narrowing of the coronary sinus lumen.
• Implantation is performed via the right internal jugular vein.

Main Results:

• The CS Reducer increases coronary venous pressure.
• This leads to redistribution of blood flow within the myocardium.
• Improved blood supply to ischemic subendocardial layers is achieved.

Conclusions:

• The CS Reducer is a novel therapeutic option for patients with severe CAD and refractory angina.
• The device improves angina symptoms and quality of life.
• It offers a new approach to managing ischemic heart conditions.